1 / 23

Clinical Compliance Programs: Investigator Payments, GCPs, and More….

Clinical Compliance Programs: Investigator Payments, GCPs, and More…. Teri Crouse, J.D. Director of Compliance for Healthcare & Marketing. High Level Overview. …And More OIG Guidance and Medical departments CME / ACCME Field-Based Medical Personnel Transparency and Firewalls OR

milla
Télécharger la présentation

Clinical Compliance Programs: Investigator Payments, GCPs, and More….

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Compliance Programs:Investigator Payments, GCPs, and More…. Teri Crouse, J.D. Director of Compliance for Healthcare & Marketing

  2. High Level Overview • …And More • OIG Guidance and Medical departments • CME / ACCME • Field-Based Medical Personnel • Transparency and Firewalls OR • How to achieve separation between commercialization and medical/scientific areas

  3. Counseling Medical on OIG Compliance • What is your client’s current perspective on compliance? • Medical generally: GCP mentality, process/SOP focused • OIG focus is INTENT: Not just what, but also why

  4. Grant ($) Pharma Company Healthcare Provider INTENT Purchase ($) “Intent” and “One Purpose” • Question is intent: not impact, not amount, not whether legitimate service was rendered,… • Kickback if any one purpose of offer is to induce …

  5. Opportunities to establish perceptions of improper intent are numerous • Example: Investigator-initiated grant program • At initiation of request • Prior to consideration • During consideration • When communicating decision • During conduct of research The standard of scrutiny • “There is no true intent, only perception of intent”

  6. “Intent” and Investigator Payments • Difficult to get Medical/Scientific areas to understand the “follow the money” mentality • Fair Market Value • What work is being performed? • What is the value of the researcher’s time “on the market”? • Are you hiring a world thought leader? • A regional thought leader? • Can this site / investigator speed up your trial? • He / she has a large pool of potential patients • He / she has a proven track record in conducting clinical research and following GCPs

  7. Question of intent in Medical Science Liaison role: • MSLs provide special medical expertise in addressing HCP questions regarding company products • vs. • MSLs discuss company products with HCPs to promote off-label uses of company products “Intent” and off-label promotion • Question of intent in medical research: Conduct and publish off-label studies to answer important scientific questions and disclose those answers to the medical community vs. Conduct and publish off-label studies to promote off-label use through investigators’ study experience and physicians hearing study results

  8. “Intent” and the For-Profit Pharma Company • “But ultimately, isn’t everything we do • designed to sell our products?” • Intent vs. consequence • General intent vs. specific intent

  9. Ensuring Behaviors Align with a Valid Intent • Exercise: • Clearly define the purpose of your activity, • Vigorously align your actions with that purpose • Challenge anything that creates contrary perceptions

  10. Ensuring Behaviors Align with a Valid IntentExample: Investigator-initiated Grant Program • Roles of Medical and Marketing • Funding source • Communications with requester • Consideration of request • Monitoring progress of research • Valid decision-making • Criteria for decision-making • Application of criteria • Source of request • Amount of request • Follow through • Structure of grant support • Monitoring progress

  11. ACCME and CME • Increasing concern over “control” by sponsors • Reaction: increased stringency on conflict of interest rules • Increased stringency toward role of sponsor in CME • What is the future of Pharma-sponsored CME?

  12. ACCME and CME • Increasing concern over “control” by sponsors • Reaction: increased stringency on conflict of interest rules • Increased stringency toward role of sponsor in CME • What is the future of Pharma-sponsored CME?

  13. Confusion over Field-Based Personnel • Sales reps vs. Medical Science Liaisons • Promotional or not? • Where to draw the line

  14. Role of the Sales Representative • To detail customers on your products • To provide samples • To provide customer service • They are the face of your company to your customers • - Being Responsive, but not always the Responder

  15. Role of the Medical Science Liaison • To interact with Thought Leader physicians • To develop relationships with potential research physicians • To help evaluate potential research physicians • To answer questions (not to prompt questions!) • To provide customer service They are also the face of your company to your customers - Being Responsive, but not always the Responder

  16. A hypothetical situation • A customer asks a sales rep if the company could provide funding for an upcoming regional medical society conference. • Does the rep respond: • Can you tell me how many other doctors on my call list will be there and will there be a presentation about my product? • No problem doc, since you are such a big writer. • C) You will have to submit a grant request to the appropriate department at my company. Here’s the information on how to submit your request.

  17. A hypothetical situation • A customer tells a sales rep she is considering doing a small study with your product and wants to know if she could get a research grant. • Does the rep respond: • I’ll check with my district manager. I think he has some extra money right now. • Only if you’re going to purchase the product. • Our medical department evaluates all research funding requests based on the scientific merit of the proposal. I can only provide you with the contact information for that department.

  18. A hypothetical situation • A customer asks your rep to do a literature search for information about one of the known side effects of your product. • How does the rep respond: • Runs to the university medical library and copies all the articles he can find. • Tells the doctor not to worry about that side effect, it’s really not a big deal. • Tells the doctor he will submit a request for your medical department to send the information they have related to the side effect.

  19. A hypothetical situation • While your rep is making a sales call on a customer who is being considered for participation as a clinical investigator, the customer complains that they have contacted the medical person at your company with a question, but haven’t received back a reply. • How does the rep respond: • Tell me your question, and I’ll contact the medical person again for you. • Tell me your question, I can probably answer it for you. • I will contact the medical person or their supervisor and ask them to get back with you as soon as possible.

  20. Policy & Procedures Corrective Actions Owner Compliance Program Implement a complete Compliance Program Discipline Process Training Monitor & Audit Communication And the answer is…. • How can you be certain that your sales reps would know that only answer C is appropriate in each of these hypothetical situations?

  21. Summary • In order to maintain the “firewall” between Sales & Marketing and Medical Personnel • Develop clear policies and procedures • Provide training on ”real world” scenarios • Monitor to assure compliance • Take corrective action, if necessary

More Related